SCHEMBL6405743

SCHEMBL6405743

COc1ccccc1-c1nnc(SCC(=O)OCc2ccccc2)n1-c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.69
CYP2C19 P33261 1/20 0.69
TP53 P04637 1/20 0.64
CNR2 P34972 1/20 0.61
CPB1 P15086 1/20 0.58
TSHR P16473 5/20 0.58
ALDH1A1 P00352 8/20 0.57
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
HPGD P15428 3/20 0.54
HSD17B10 Q99714 2/20 0.54
MEN1 O00255 1/20 0.54
USP2 O75604 1/20 0.54
KMT2A Q03164 1/20 0.54
LMNA P02545 1/20 0.53
PKM P14618 1/20 0.52
ALOX15 P16050 1/20 0.52
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410634 0.92 CYP3A4 (0.61) CYP3A4CYP2C19TP53CNR2CPB1
SCHEMBL6405988 0.88 ALDH1A1 (0.57) CYP3A4CYP2C19TP53TSHRALDH1A1
SCHEMBL6404903 0.86 TSHR (0.57) CYP3A4CYP2C19CPB1TSHRALDH1A1
SCHEMBL5717657 0.86 ALDH1A1 (0.76) CYP3A4CYP2C19TP53CNR2CPB1
SCHEMBL6410767 0.85 KDM4E (0.55) CYP3A4CYP2C19TP53TSHRALDH1A1
SCHEMBL6404213 0.85 MEN1 (0.62) CYP3A4CYP2C19TP53TSHRALDH1A1
SCHEMBL5717661 0.84 TP53 (0.70) CYP3A4CYP2C19TP53CNR2TSHR
SCHEMBL6404543 0.83 MAPT (0.64) CYP3A4CYP2C19TP53TSHRALDH1A1
SCHEMBL6407998 0.82 TSHR (0.72) TSHRALDH1A1NPC1HPGDHSD17B10
SCHEMBL6404073 0.82 ALDH1A1 (0.63) TP53ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP3A4 25/4885CYP2C19 142/4885TP53 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.